You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 264 No. 23, December 19, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Reviews
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cholesterol and Coronary Heart Disease

Future Directions

Scott M. Grundy, MD, PhD

JAMA. 1990;264(23):3053-3059.


Abstract

The importance of high serum cholesterol levels as a risk factor for coronary heart disease and the benefit of lowering cholesterol levels for reducing risk are being increasingly accepted. A broad consensus to this effect has led to the establishment of the National Cholesterol Education Program. Although the available evidence fully justifies this program, its practical application to the American public has generated a series of new questions that must be explored. For example, it can be questioned whether reduction in coronary risk through lowering cholesterol levels extends to both sexes and all age groups. For people with high cholesterol levels, dietary modification is undoubtedly the first step of management, but the fraction of people responding adequately to dietary change remains to be determined. Finally, indications for drug therapy and choice of drugs need further exploration, particularly in the area of cost vs benefit. Thus, continuing research must be carried out in parallel with clinical and public health application of cholesterol education.

(JAMA. 1990;264:3053-3059)



Author Affiliations

From the Center for Human Nutrition, Departments of Biochemistry, Internal Medicine, and Clinical Nutrition, University of Texas Southwestern Medical Center at Dallas; and Veterans Administration Medical Center, Dallas, Tex.


Footnotes

Reprint requests to Center for Human Nutrition, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235-9052 (Dr Grundy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Membrane topology of human NPC1L1, a key protein in enterohepatic cholesterol absorption
Wang et al.
J. Lipid Res. 2009;50:1653-1662.
ABSTRACT | FULL TEXT  

Native LDL Increases Endothelial Cell Adhesiveness by Inducing Intercellular Adhesion Molecule–1
Smalley et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:585-590.
ABSTRACT | FULL TEXT  

Evaluating Cholesterol Screening: The Importance of Controlling for Regression to the Mean
Forrow et al.
Arch Intern Med 1995;155:2177-2184.
ABSTRACT  

Serum Lipid Screening to Identify High-Risk Individuals for Coronary Death: The Results of the Lipid Research Clinics Prevalence Cohort
Grover et al.
Arch Intern Med 1994;154:679-684.
ABSTRACT  

Membranous Nephropathy
Austin et al.
ANN INTERN MED 1992;116:672-682.
ABSTRACT  

Plasma Lipid Lowering in Short-term Life-style Change
Grundy
Arch Intern Med 1991;151:1275-1276.
ABSTRACT  

Detection and Treatment of Elevated Blood Cholesterol: What Have We Learned?
Dalen
Arch Intern Med 1991;151:25-28.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.